Moreover, LncRNA LUCAT1 expression was significantly increased in various cancers, such as liver cancer,18 triple‐negative breast cancer,19 gastric cancer,20 colorectal cancer,21 cervical cancer,22 hepatocellular carcinoma,23 and glioma,24 serving as a valuable biomarker in clinical treatment. This evidence concerns the gene LUCAT1 and central nervous system cancer.